Mindray Medical Reports Higher Q2 Profit; Raises Full-Year Guidance (MR)

Mindray Medical (NYSE: MR ) released its fiscal second-quarter earnings results after the closing bell on Monday. The company reported earnings per share that were ahead of analysts' consensus estimates, but sales fell short of expectations. Mindray also raised its full-year revenue guidance. In late trade, the share price